917481-96-0

Upstream product

• 917396-29-3 3-(chloromethyl)-2-methyl-6-(trifluoromethyl)pyridine 
• 917481-95-9 4-(5-(4-chlorophenyl)-3-oxo-2,3-dihydropyridazin-4-yl)benzonitrile 
• 1034414-34-0 4-(6-bromo-5-(4-chlorophenyl)-3-oxo-2,3-dihydropyridazin-4-yl)benzonitrile 

Downstream Products

• 1034414-82-8 4-(5-(4-chlorophenyl)-6-hydrazinyl-2-((2-methyl-6-(trifluoromethyl)-pyridin-3-yl)methyl)-3-oxo-2,3-dihydropyridazin-4-yl)-benzonitrile 

Relevant academic research and scientific papers

AZABICYCLIC HETEROCYCLES AS CANNABINOID RECEPTOR MODULATORS

The present application describes compounds according to Formula I and Ia, pharmaceutical compositions comprising at least one compound according to Formula I or Ia, and optionally one or more additional therapeutic agents and methods of treatment using t

Azabicyclic heterocycles as cannabinoid receptor modulators

The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula I and Formula II: including all prodrugs, pharmaceutically acceptable salts and stereoisomers, R1, R2, R3 and R4 are described herein.